Search results
Showing 2461 to 2475 of 8899 results
Baxdrostat for treating uncontrolled or resistant hypertension [ID6623]
In development Reference number: GID-TA11818 Expected publication date: TBC
Pirtobrutinib for untreated chronic lymphocytic leukaemia or small lymphocytic lymphoma [ID6397]
In development Reference number: GID-TA11501 Expected publication date: TBC
We are listening to your views on this Technology appraisal guidance. Comments close 11 February 2026.
We are listening to your views on this Technology appraisal guidance. Comments close 9 February 2026.
We are listening to your views on this Technology appraisal guidance. Comments close 11 February 2026.
We are listening to your views on this Technology appraisal guidance. Comments close 12 February 2026.
In development Reference number: GID-TA11765 Expected publication date: TBC
Pimicotinib for treating tenosynovial giant cell tumours when systemic treatment is needed [ID6647]
In development Reference number: GID-TA11859 Expected publication date: TBC
In development Reference number: GID-QS10186 Expected publication date: 19 March 2026
Iptacopan for treating complement 3 glomerulopathy in people 12 to 18 years [TSID12315]
Awaiting development Reference number: GID-TA11913 Expected publication date: TBC
Luspatercept for Anaemia due to myelodysplastic syndromes [TSID12310]
Awaiting development Reference number: GID-TA11914 Expected publication date: TBC
Awaiting development Reference number: GID-TA11911 Expected publication date: TBC
Tirzepatide for managing overweight and obesity in people 12 to 17 years [TSID12322]
Awaiting development Reference number: GID-TA11923 Expected publication date: TBC
Orforglipron for treating obstructive sleep apnoea associated with obesity or overweight [TSID12323]
Awaiting development Reference number: GID-TA11916 Expected publication date: TBC
Ravulizumab for treating primary IgA nephropathy [TSID12313]
Awaiting development Reference number: GID-TA11919 Expected publication date: TBC